Home > Healthcare > Biotechnology > Biopharma > Immunoglobulin Market

Immunoglobulin Market Share

Report ID: GMI5752
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Immunoglobulin Market Share

Some of the major market players operating in the immunoglobulin market are

Baxter international Inc.
Johnson & Johnson (Omrix Biopharmaceuticals Inc.)
Pfizer Inc.
Takeda Pharmaceutical Company Limited
Grifols SA
Kedrion S.p.A
CSL Behring

These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Immunoglobulin industry was valued at around USD 15.3 billion in 2022 and is estimated to reach USD 32.2 billion by the end of 2032, owing to the increasing prevalence of immunodeficiency diseases.

The chronic inflammatory demyelinating polyneuropathy (CIDP) segment is expected to grow at a steady pace of 8% between 2023 to 2032, as CIDP treatment typically involves the use of immunosuppressants, steroids, and plasmapheresis.

U.S. immunoglobulin market held a revenue of USD 7.6 billion in 2022 and will continue to grow attributed to the increasing healthcare spending, growing awareness about treatment, and the rising preference among physicians for immunodeficiency therapies.

Baxter international Inc., Johnson & Johnson (Omrix Biopharmaceuticals Inc.), Pfizer Inc., Takeda Pharmaceutical Company Limited, Grifols SA, Kedrion S.p.A, and CSL Behring, among others.